As of August 29, 2026, Damora Therapeutics, Inc. (DMRA) has a DilutionWatch DilutionScore of 51/100, rated HIGH dilution risk. Damora Therapeutics, Inc. has a market capitalization of $1.53B, 61.74M shares outstanding.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for DMRA.
Market Data
Market Cap$1.53B
Shares Outstanding61.74M
Float41.22M
Cash$576.50M
DebtN/A
Short InterestN/A
Institutional Holdings
91.0% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
Short Interest
Short Interest4.89M
Days to Cover11.7
% of Float11.9%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2020-12-31
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual DMRA Dilution Snapshot
Damora Therapeutics, Inc. (DMRA) has a DilutionScore of 51/100, rated High dilution risk. Score date: August 29, 2026.
- Recent SEC activity tracked for DMRA: xbrl on 2020-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track DMRA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking DMRA — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for DMRA
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.